• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register

Teriparatide Acetate

Product ID T1675
Cas No. 52232-67-4
Purity ≥95%
Product Unit SizeCostQuantityStock
0.5 mg $170.70 In stock
1 mg $323.70 In stock
2.5 mg $647.50 In stock
Bulk Quote
Add to Wishlist

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Teriparatide is also known as recombinant human parathyroid hormone (1-34) and it exhibits anabolic effects on bone. Teriparatide is an anti-osteoporotic drug that is clinically used to treat osteoporosis; it does not exhibit anti-resorptive benefit, but stimulates bone formation and increases bone strength. Teriparatide activates the PTH1 receptor. In clinical settings, teriparatide decreases new fracture occurrence and back pain and increases lumbar spinal bone mineral density. In mouse bone marrow stromal cells, teriparatide upregulates expression of osterix and Runx2; in paired animal models, this compound increases osteoblast maturation and improves fracture healing.

Product Info

Cas No.

52232-67-4

Purity

≥95%

Formula

C181H291N55O51S2

Formula Wt.

4117.72

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

T1675 MSDS PDF

Info Sheet

T1675 Info Sheet PDF

References

Tseng YY, Su CH, Lui TN, et al. Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture after percutaneous vertebroplasty. Osteoporos Int. 2012 May;23(5):1613-22. PMID: 21769661.

File E, Deal C. Clinical update on teriparatide. Curr Rheumatol Rep. 2009 Jul;11(3):169-76. PMID: 19604460.

Kaback LA, Soung do Y, Naik A, et al. Teriparatide (1-34 human PTH) regulation of osterix during fracture repair. J Cell Biochem. 2008 Sep 1;105(1):219-26. PMID: 18494002.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2023 LKT Laboratories, All Rights Reserved - Products for research use only